Company Search:
Advanced Search
Sponsored Links
Valneva SE Company Snapshot
Valneva SE operates within the Medicinals and botanicals sector. In addition to historical fundamental analyses, the complete report available to purchase compares Valneva SE with three other pharmaceutical manufacturers in Europe: Cathay International Holdings Ltd of the United Kingdom (2016 sales of £88.07 million [US$117.27 million] ), Zentiva SA of Romania (420.00 million Romanian Leu [US$108.73 million] ), and Advanced Medical Solutions Group plc which is based in the United Kingdom (£82.62 million [US$110.01 million] of which 39% was OEM).

Sales Analysis. During the year ended December of 2016, sales at Valneva SE were 94.06 million Euro (US$111.58 million). This is an increase of 20.0% versus 2015, when the company's sales were 78.36 million Euro. This was the fourth straight year of sales growth at Valneva SE. Sales of Commercialized Vaccines saw an increase of 30.2% in 2016, from 62.05 million Euro to 80.82 million Euro. Not all segments of Valneva SE experienced an increase in sales in 2016: sales of Technologies and Services fell 44.5% to 6.99 million Euro.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Valneva SE
  Stock Performance Chart for Valneva SE
  Stock Data: Recent Stock Performance:
  Current Price (10/13/2017): 2.85
(Figures in Euro)
1 Week -2.4%   13 Weeks -3.4%  
4 Weeks -1.0%   52 Weeks 10.5%  
Valneva SE Key Data:
  Ticker: VLA Country: France
  Exchanges: PAR Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Medicinals & Botanicals
  2016 Sales 94,062,000
(Year Ending Jan 2017).
Employees: 417
  Currency: Euro Market Cap: 220,759,478
  Fiscal Yr Ends: December Shares Outstanding: 77,459,466
  Share Type: Actions Ordinaires Closely Held Shares: 13,744,679
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.